Dolski Robert 4
4 · Checkmate Pharmaceuticals, Inc. · Filed Aug 6, 2021
Insider Transaction Report
Form 4
Dolski Robert
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-04+27,300→ 27,300 totalExercise: $5.09Exp: 2031-08-03→ Common Stock (27,300 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vest and become exercisable on August 4, 2022 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.